Sigma Planning Corp Gilead Sciences, Inc. Transaction History

Sigma Planning Corp

$3.16 Billion
Q2 2024

A detailed history of Sigma Planning Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sigma Planning Corp holds 43,901 shares of GILD stock, worth $3.69 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

43,901

Previous 38,550 13.88%

Holding current value

$3.69 Million

Previous $2.82 Million 6.7%

% of portfolio

0.1%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$63.15 - $72.88 $337,915 - $389,980	5,351 Added 13.88%	43,901 $3.01 Million
Q1 2024 May 01, 2024	BUY	$71.58 - $87.29 $1.54 Million - $1.88 Million	21,581 Added 127.18%	38,550 $2.82 Million
Q4 2023 Feb 01, 2024	SELL	$73.27 - $83.09 $1.66 Million - $1.88 Million	-22,684 Reduced 57.21%	16,969 $1.37 Million
Q3 2023 Nov 06, 2023	SELL	$73.94 - $80.67 $76,084 - $83,009	-1,029 Reduced 2.53%	39,653 $2.97 Million
Q2 2023 Aug 01, 2023	SELL	$76.01 - $86.7 $303,127 - $345,759	-3,988 Reduced 8.93%	40,682 $3.14 Million
Q1 2023 May 05, 2023	SELL	$77.31 - $88.08 $541,788 - $617,264	-7,008 Reduced 13.56%	44,670 $3.71 Million
Q4 2022 Jan 24, 2023	SELL	$62.32 - $89.47 $277,261 - $398,052	-4,449 Reduced 7.93%	51,678 $0
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $190,349 - $217,427	3,197 Added 6.04%	56,127 $3.46 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $925,540 - $1.04 Million	16,035 Added 43.46%	52,930 $3.27 Million
Q1 2022 Apr 20, 2022	BUY	$57.92 - $72.58 $358,524 - $449,270	6,190 Added 20.16%	36,895 $2.19 Million
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $92,129 - $104,568	1,420 Added 4.85%	30,705 $2.23 Million
Q3 2021 Oct 28, 2021	SELL	$67.69 - $73.03 $622,138 - $671,218	-9,191 Reduced 23.89%	29,285 $2.05 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $280,283 - $306,249	4,416 Added 12.97%	38,476 $2.65 Million
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $19,260 - $21,975	321 Added 0.95%	34,060 $2.2 Million
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $97,268 - $110,832	-1,717 Reduced 4.84%	33,739 $1.97 Million
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $87,995 - $110,639	1,417 Added 4.16%	35,456 $2.24 Million
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $6,293 - $7,308	87 Added 0.26%	34,039 $2.62 Million
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $590,663 - $756,554	9,431 Added 38.46%	33,952 $2.54 Million
Q4 2019 Feb 03, 2020	BUY	$61.62 - $67.78 $530,055 - $583,043	8,602 Added 54.04%	24,521 $1.59 Million
Q3 2019 Nov 01, 2019	BUY	$62.51 - $69.0 $136,334 - $150,489	2,181 Added 15.88%	15,919 $1.01 Million
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $93,114 - $104,416	-1,505 Reduced 9.87%	13,738 $928,000
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $22,323 - $25,007	-357 Reduced 2.29%	15,243 $991,000
Q4 2018 Jan 31, 2019	SELL	$60.54 - $79.0 $57,815 - $75,445	-955 Reduced 5.77%	15,600 $976,000
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $534,813 - $592,136	-7,503 Reduced 31.19%	16,555 $1.28 Million
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $88,301 - $103,000	-1,361 Reduced 5.35%	24,058 $1.7 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $380,370 - $463,713	-5,222 Reduced 17.04%	25,419 $1.92 Million
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $214,161 - $251,395	3,010 Added 10.89%	30,641 $2.2 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $1.99 Million - $2.36 Million	27,631	27,631 $2.24 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Gilead Sciences, Inc. Transaction History